148 related articles for article (PubMed ID: 28937296)
1. Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2018 Feb; 34(2):171-174. PubMed ID: 28937296
[TBL] [Abstract][Full Text] [Related]
2. STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different estrogen receptor-α immunoprofile.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Koda M; Sulkowska U; Famulski W; Sulkowski S
Gynecol Endocrinol; 2011 Aug; 27(8):536-40. PubMed ID: 21726118
[TBL] [Abstract][Full Text] [Related]
3. Eventual proapoptotic or anti-apoptotic impact of aberrantly expressed Cx43 and Cx26 can depend on ER-alpha overexpression in human endometrioid adenocarcinoma.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2015; 31(8):604-8. PubMed ID: 26299454
[TBL] [Abstract][Full Text] [Related]
4. Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas.
Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Sulkowski S
Tissue Cell; 2008 Dec; 40(6):405-10. PubMed ID: 18579174
[TBL] [Abstract][Full Text] [Related]
5. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of apoptosis-associated proteins: p53, Bcl-xL, Bax and Bak in gastric cancer cells in correlation with clinical and pathomorphological factors.
Gryko M; Pryczynicz A; Guzińska-Ustymowicz K; Kamocki Z; Zaręba K; Kemona A; Kędra B
Adv Med Sci; 2012 Jun; 57(1):77-83. PubMed ID: 22440942
[TBL] [Abstract][Full Text] [Related]
7. Aberrant distributions and relationships among E-cadherin, beta-catenin, and connexin 26 and 43 in endometrioid adenocarcinomas.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Lesniewicz T; Rutkowski R; Sobaniec-Lotowska M; Sulkowski S; Koda M; Sulkowska M
Int J Gynecol Pathol; 2010 Jul; 29(4):358-65. PubMed ID: 20567150
[TBL] [Abstract][Full Text] [Related]
8. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
[TBL] [Abstract][Full Text] [Related]
9. The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas.
Blechschmidt K; Kremmer E; Hollweck R; Mylonas I; Höfler H; Kremer M; Becker KF
Diagn Mol Pathol; 2007 Dec; 16(4):222-8. PubMed ID: 18043286
[TBL] [Abstract][Full Text] [Related]
10. The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas.
Brüning A; Jückstock J; Blankenstein T; Makovitzky J; Kunze S; Mylonas I
Histol Histopathol; 2010 Nov; 25(11):1447-56. PubMed ID: 20865667
[TBL] [Abstract][Full Text] [Related]
11. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
13. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of Twist, E-cadherin, and N-cadherin protein expression in endometrioid adenocarcinoma.
Xie X; Zheng X; Wang J; Chen L
J Cancer Res Ther; 2017; 13(5):817-822. PubMed ID: 29237910
[TBL] [Abstract][Full Text] [Related]
15. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.
Ogura E; Senzaki H; Yamamoto D; Yoshida R; Takada H; Hioki K; Tsubura A
Oncol Rep; 1999; 6(2):365-9. PubMed ID: 10023006
[TBL] [Abstract][Full Text] [Related]
17. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK
Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
19. The E-Cadherin expression vs. tumor cell proliferation paradox in endometrial cancer.
González-Rodilla I; Aller L; Llorca J; Muñoz AB; Verna V; Estévez J; Schneider J
Anticancer Res; 2013 Nov; 33(11):5091-5. PubMed ID: 24222154
[TBL] [Abstract][Full Text] [Related]
20. STAT3 and hypoxia induced proteins--HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancers.
Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Wincewicz D; Sulkowski S
Folia Histochem Cytobiol; 2009 Jan; 47(3):425-30. PubMed ID: 20164027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
